Global Molecular Diagnostic Kits Market Growth 2025-2031

Publication ID:

LPI04255255

Publication Date:

April 9, 2025

Pages:

144

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Molecular Diagnostic Kits market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The global molecular diagnostic kits market is expected to witness significant growth due to increasing disease prevalence, advancements in personalized medicine, and technological innovations. Continued research and development, collaborations between industry stakeholders and healthcare providers, addressing reimbursement challenges, and improving accessibility in under-served regions will drive market expansion and enable molecular diagnostic kits to contribute to more accurate and personalized patient care.
The 鈥淢olecular Diagnostic Kits Industry Forecast鈥� looks at past sales and reviews total world Molecular Diagnostic Kits sales in 2024, providing a comprehensive analysis by region and market sector of projected Molecular Diagnostic Kits sales for 2025 through 2031. With Molecular Diagnostic Kits sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Diagnostic Kits industry.
This Insight Report provides a comprehensive analysis of the global Molecular Diagnostic Kits landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Molecular Diagnostic Kits portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Molecular Diagnostic Kits market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Diagnostic Kits and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Diagnostic Kits.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Diagnostic Kits market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
PCR
Gene Chip
Fluorescence in Situ Hybridization
DNA Sequencing
Segmentation by Application:
Infectious Disease Diagnosis
Genetic Diagnosis
Blood Screening
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche
Danaher
Hologic
Grifols
叠颈辞惭茅谤颈别耻虫
Qiagen
Abbott
Thermo Fisher
Bio-Rad
Illumina
Siemens
Agilent
Daangene
Diasorin
Merck
KHB
liferiver
Leadman
Triplex
BGI
Key Questions Addressed in this Report
What is the 10-year outlook for the global Molecular Diagnostic Kits market?
What factors are driving Molecular Diagnostic Kits market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Molecular Diagnostic Kits market opportunities vary by end market size?
How does Molecular Diagnostic Kits break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Molecular Diagnostic Kits Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Molecular Diagnostic Kits by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Molecular Diagnostic Kits by Country/Region, 2020, 2024 & 2031
2.2 Molecular Diagnostic Kits Segment by Type
2.2.1 PCR
2.2.2 Gene Chip
2.2.3 Fluorescence in Situ Hybridization
2.2.4 DNA Sequencing
2.3 Molecular Diagnostic Kits Sales by Type
2.3.1 Global Molecular Diagnostic Kits Sales Market Share by Type (2020-2025)
2.3.2 Global Molecular Diagnostic Kits Revenue and Market Share by Type (2020-2025)
2.3.3 Global Molecular Diagnostic Kits Sale Price by Type (2020-2025)
2.4 Molecular Diagnostic Kits Segment by Application
2.4.1 Infectious Disease Diagnosis
2.4.2 Genetic Diagnosis
2.4.3 Blood Screening
2.4.4 Other
2.5 Molecular Diagnostic Kits Sales by Application
2.5.1 Global Molecular Diagnostic Kits Sale Market Share by Application (2020-2025)
2.5.2 Global Molecular Diagnostic Kits Revenue and Market Share by Application (2020-2025)
2.5.3 Global Molecular Diagnostic Kits Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Molecular Diagnostic Kits Breakdown Data by Company
3.1.1 Global Molecular Diagnostic Kits Annual Sales by Company (2020-2025)
3.1.2 Global Molecular Diagnostic Kits Sales Market Share by Company (2020-2025)
3.2 Global Molecular Diagnostic Kits Annual Revenue by Company (2020-2025)
3.2.1 Global Molecular Diagnostic Kits Revenue by Company (2020-2025)
3.2.2 Global Molecular Diagnostic Kits Revenue Market Share by Company (2020-2025)
3.3 Global Molecular Diagnostic Kits Sale Price by Company
3.4 Key Manufacturers Molecular Diagnostic Kits Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Molecular Diagnostic Kits Product Location Distribution
3.4.2 Players Molecular Diagnostic Kits Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Molecular Diagnostic Kits by Geographic Region
4.1 World Historic Molecular Diagnostic Kits Market Size by Geographic Region (2020-2025)
4.1.1 Global Molecular Diagnostic Kits Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Molecular Diagnostic Kits Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Molecular Diagnostic Kits Market Size by Country/Region (2020-2025)
4.2.1 Global Molecular Diagnostic Kits Annual Sales by Country/Region (2020-2025)
4.2.2 Global Molecular Diagnostic Kits Annual Revenue by Country/Region (2020-2025)
4.3 Americas Molecular Diagnostic Kits Sales Growth
4.4 APAC Molecular Diagnostic Kits Sales Growth
4.5 Europe Molecular Diagnostic Kits Sales Growth
4.6 Middle East & Africa Molecular Diagnostic Kits Sales Growth
5 Americas
5.1 Americas Molecular Diagnostic Kits Sales by Country
5.1.1 Americas Molecular Diagnostic Kits Sales by Country (2020-2025)
5.1.2 Americas Molecular Diagnostic Kits Revenue by Country (2020-2025)
5.2 Americas Molecular Diagnostic Kits Sales by Type (2020-2025)
5.3 Americas Molecular Diagnostic Kits Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Diagnostic Kits Sales by Region
6.1.1 APAC Molecular Diagnostic Kits Sales by Region (2020-2025)
6.1.2 APAC Molecular Diagnostic Kits Revenue by Region (2020-2025)
6.2 APAC Molecular Diagnostic Kits Sales by Type (2020-2025)
6.3 APAC Molecular Diagnostic Kits Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Molecular Diagnostic Kits by Country
7.1.1 Europe Molecular Diagnostic Kits Sales by Country (2020-2025)
7.1.2 Europe Molecular Diagnostic Kits Revenue by Country (2020-2025)
7.2 Europe Molecular Diagnostic Kits Sales by Type (2020-2025)
7.3 Europe Molecular Diagnostic Kits Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Molecular Diagnostic Kits by Country
8.1.1 Middle East & Africa Molecular Diagnostic Kits Sales by Country (2020-2025)
8.1.2 Middle East & Africa Molecular Diagnostic Kits Revenue by Country (2020-2025)
8.2 Middle East & Africa Molecular Diagnostic Kits Sales by Type (2020-2025)
8.3 Middle East & Africa Molecular Diagnostic Kits Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Molecular Diagnostic Kits
10.3 Manufacturing Process Analysis of Molecular Diagnostic Kits
10.4 Industry Chain Structure of Molecular Diagnostic Kits
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Molecular Diagnostic Kits Distributors
11.3 Molecular Diagnostic Kits Customer
12 World Forecast Review for Molecular Diagnostic Kits by Geographic Region
12.1 Global Molecular Diagnostic Kits Market Size Forecast by Region
12.1.1 Global Molecular Diagnostic Kits Forecast by Region (2026-2031)
12.1.2 Global Molecular Diagnostic Kits Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Molecular Diagnostic Kits Forecast by Type (2026-2031)
12.7 Global Molecular Diagnostic Kits Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Molecular Diagnostic Kits Product Portfolios and Specifications
13.1.3 Roche Molecular Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Danaher
13.2.1 Danaher Company Information
13.2.2 Danaher Molecular Diagnostic Kits Product Portfolios and Specifications
13.2.3 Danaher Molecular Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Danaher Main Business Overview
13.2.5 Danaher Latest Developments
13.3 Hologic
13.3.1 Hologic Company Information
13.3.2 Hologic Molecular Diagnostic Kits Product Portfolios and Specifications
13.3.3 Hologic Molecular Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Hologic Main Business Overview
13.3.5 Hologic Latest Developments
13.4 Grifols
13.4.1 Grifols Company Information
13.4.2 Grifols Molecular Diagnostic Kits Product Portfolios and Specifications
13.4.3 Grifols Molecular Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Grifols Main Business Overview
13.4.5 Grifols Latest Developments
13.5 叠颈辞惭茅谤颈别耻虫
13.5.1 叠颈辞惭茅谤颈别耻虫 Company Information
13.5.2 叠颈辞惭茅谤颈别耻虫 Molecular Diagnostic Kits Product Portfolios and Specifications
13.5.3 叠颈辞惭茅谤颈别耻虫 Molecular Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 叠颈辞惭茅谤颈别耻虫 Main Business Overview
13.5.5 叠颈辞惭茅谤颈别耻虫 Latest Developments
13.6 Qiagen
13.6.1 Qiagen Company Information
13.6.2 Qiagen Molecular Diagnostic Kits Product Portfolios and Specifications
13.6.3 Qiagen Molecular Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Qiagen Main Business Overview
13.6.5 Qiagen Latest Developments
13.7 Abbott
13.7.1 Abbott Company Information
13.7.2 Abbott Molecular Diagnostic Kits Product Portfolios and Specifications
13.7.3 Abbott Molecular Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Abbott Main Business Overview
13.7.5 Abbott Latest Developments
13.8 Thermo Fisher
13.8.1 Thermo Fisher Company Information
13.8.2 Thermo Fisher Molecular Diagnostic Kits Product Portfolios and Specifications
13.8.3 Thermo Fisher Molecular Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Thermo Fisher Main Business Overview
13.8.5 Thermo Fisher Latest Developments
13.9 Bio-Rad
13.9.1 Bio-Rad Company Information
13.9.2 Bio-Rad Molecular Diagnostic Kits Product Portfolios and Specifications
13.9.3 Bio-Rad Molecular Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Bio-Rad Main Business Overview
13.9.5 Bio-Rad Latest Developments
13.10 Illumina
13.10.1 Illumina Company Information
13.10.2 Illumina Molecular Diagnostic Kits Product Portfolios and Specifications
13.10.3 Illumina Molecular Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Illumina Main Business Overview
13.10.5 Illumina Latest Developments
13.11 Siemens
13.11.1 Siemens Company Information
13.11.2 Siemens Molecular Diagnostic Kits Product Portfolios and Specifications
13.11.3 Siemens Molecular Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Siemens Main Business Overview
13.11.5 Siemens Latest Developments
13.12 Agilent
13.12.1 Agilent Company Information
13.12.2 Agilent Molecular Diagnostic Kits Product Portfolios and Specifications
13.12.3 Agilent Molecular Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Agilent Main Business Overview
13.12.5 Agilent Latest Developments
13.13 Daangene
13.13.1 Daangene Company Information
13.13.2 Daangene Molecular Diagnostic Kits Product Portfolios and Specifications
13.13.3 Daangene Molecular Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Daangene Main Business Overview
13.13.5 Daangene Latest Developments
13.14 Diasorin
13.14.1 Diasorin Company Information
13.14.2 Diasorin Molecular Diagnostic Kits Product Portfolios and Specifications
13.14.3 Diasorin Molecular Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Diasorin Main Business Overview
13.14.5 Diasorin Latest Developments
13.15 Merck
13.15.1 Merck Company Information
13.15.2 Merck Molecular Diagnostic Kits Product Portfolios and Specifications
13.15.3 Merck Molecular Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Merck Main Business Overview
13.15.5 Merck Latest Developments
13.16 KHB
13.16.1 KHB Company Information
13.16.2 KHB Molecular Diagnostic Kits Product Portfolios and Specifications
13.16.3 KHB Molecular Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 KHB Main Business Overview
13.16.5 KHB Latest Developments
13.17 liferiver
13.17.1 liferiver Company Information
13.17.2 liferiver Molecular Diagnostic Kits Product Portfolios and Specifications
13.17.3 liferiver Molecular Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 liferiver Main Business Overview
13.17.5 liferiver Latest Developments
13.18 Leadman
13.18.1 Leadman Company Information
13.18.2 Leadman Molecular Diagnostic Kits Product Portfolios and Specifications
13.18.3 Leadman Molecular Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Leadman Main Business Overview
13.18.5 Leadman Latest Developments
13.19 Triplex
13.19.1 Triplex Company Information
13.19.2 Triplex Molecular Diagnostic Kits Product Portfolios and Specifications
13.19.3 Triplex Molecular Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Triplex Main Business Overview
13.19.5 Triplex Latest Developments
13.20 BGI
13.20.1 BGI Company Information
13.20.2 BGI Molecular Diagnostic Kits Product Portfolios and Specifications
13.20.3 BGI Molecular Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 BGI Main Business Overview
13.20.5 BGI Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂